Global CAR T-Cell Therapy Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

This in-depth market research offers all the details related to the growth potential of the CAR T-Cell Therapy Market, which can help interested party get a clear picture about the present and future key trends and prospects of the CAR T-Cell Therapy market. Furthermore, the report incorporates the information regarding the growth opportunities & challenges and competitive scenarios of the market on the global scale. The report provides all the necessary information using primary and secondary sources coupled with variety of tools. The market analysis provided in the report provides a panoramic view of the market growth potential and better understanding of the future market scope and opportunities. The report touches upon the vital factors such as market size and market growth rate after analyzing the market even during the COVID-19 outbreak.

Data provided by Extent Research. Source: https://www.extentresearch.com/car-t-cell-therapy-market

The virus outbreak is found to have brought about a dynamic change in the industry and the entire economic condition. This report also covers the analysis of the influence of the COVID-19 pandemic on market dynamic and revenue. In addition to this, all the present and future aspects of the CAR T-Cell Therapy market is penciled down after thorough market analysis. Moreover, the segmentation of the market by Product type Allogeneic, Autologous, , by Application Hospitals, Cancer Research Centers, Others, , company profiles of Celgene (Juno Therapeutics), Novartis, Gilead (Kite Pharma), Pfizer, CARsgen Therapeutics, Autolus Therapeutics, Aurora BioPharma, Sorrento Therapeutics, Mustang Bio, Bluebird Bio, Collectis, Allogene Therapeutics, Celyad, , types, and others is anticipated to help understand the product position and market popularity in the forecast years.

The comprehensive research report covers all the historical data and forecast estimation as well. Thereby, the extensive CAR T-Cell Therapy market analysis on the regional and competitive landscape gives a brief idea about the product development, sales, demand & supply trends, regional market share, and size. The research report offered by Extent Research offers an up-to-date insight of the CAR T-Cell Therapy market. The emerging drivers and trends of the market that are projected to influence the industry growth are also mentioned in the report. Speaking of CAR T-Cell Therapy market report, it covers all the market size & growth, market dynamics, opportunities & challenges, competitive landscape, and regional breakdown.

Report Scope and Market Segmentation

ATTRIBUTES	Global CAR T-Cell Therapy Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global CAR T-Cell Therapy Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Allogeneic
        1.2.3 Autologous
    1.3 Market by Application
        1.3.1 Global CAR T-Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospitals
        1.3.3 Cancer Research Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CAR T-Cell Therapy Market Perspective (2017-2035)
    2.2 CAR T-Cell Therapy Growth Trends by Region
        2.2.1 CAR T-Cell Therapy Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2023-2035)
    2.3 CAR T-Cell Therapy Market Dynamics
        2.3.1 CAR T-Cell Therapy Industry Trends
        2.3.2 CAR T-Cell Therapy Market Drivers
        2.3.3 CAR T-Cell Therapy Market Challenges
        2.3.4 CAR T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CAR T-Cell Therapy Players by Revenue
        3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
    3.4 Global CAR T-Cell Therapy Market Concentration Ratio
        3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2021
    3.5 CAR T-Cell Therapy Key Players Head office and Area Served
    3.6 Key Players CAR T-Cell Therapy Product Solution and Service
    3.7 Date of Enter into CAR T-Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Breakdown Data by Type
    4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2035)
5 CAR T-Cell Therapy Breakdown Data by Application
    5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America CAR T-Cell Therapy Market Size (2017-2035)
    6.2 North America CAR T-Cell Therapy Market Size by Type
        6.2.1 North America CAR T-Cell Therapy Market Size by Type (2017-2022)
        6.2.2 North America CAR T-Cell Therapy Market Size by Type (2023-2035)
        6.2.3 North America CAR T-Cell Therapy Market Share by Type (2017-2035)
    6.3 North America CAR T-Cell Therapy Market Size by Application
        6.3.1 North America CAR T-Cell Therapy Market Size by Application (2017-2022)
        6.3.2 North America CAR T-Cell Therapy Market Size by Application (2023-2035)
        6.3.3 North America CAR T-Cell Therapy Market Share by Application (2017-2035)
    6.4 North America CAR T-Cell Therapy Market Size by Country
        6.4.1 North America CAR T-Cell Therapy Market Size by Country (2017-2022)
        6.4.2 North America CAR T-Cell Therapy Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe CAR T-Cell Therapy Market Size (2017-2035)
    7.2 Europe CAR T-Cell Therapy Market Size by Type
        7.2.1 Europe CAR T-Cell Therapy Market Size by Type (2017-2022)
        7.2.2 Europe CAR T-Cell Therapy Market Size by Type (2023-2035)
        7.2.3 Europe CAR T-Cell Therapy Market Share by Type (2017-2035)
    7.3 Europe CAR T-Cell Therapy Market Size by Application
        7.3.1 Europe CAR T-Cell Therapy Market Size by Application (2017-2022)
        7.3.2 Europe CAR T-Cell Therapy Market Size by Application (2023-2035)
        7.3.3 Europe CAR T-Cell Therapy Market Share by Application (2017-2035)
    7.4 Europe CAR T-Cell Therapy Market Size by Country
        7.4.1 Europe CAR T-Cell Therapy Market Size by Country (2017-2022)
        7.4.2 Europe CAR T-Cell Therapy Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2017-2035)
    8.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific CAR T-Cell Therapy Market Share by Type (2017-2035)
    8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific CAR T-Cell Therapy Market Share by Application (2017-2035)
    8.4 Asia-Pacific CAR T-Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America CAR T-Cell Therapy Market Size (2017-2035)
    9.2 Latin America CAR T-Cell Therapy Market Size by Type
        9.2.1 Latin America CAR T-Cell Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America CAR T-Cell Therapy Market Size by Type (2023-2035)
        9.2.3 Latin America CAR T-Cell Therapy Market Share by Type (2017-2035)
    9.3 Latin America CAR T-Cell Therapy Market Size by Application
        9.3.1 Latin America CAR T-Cell Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America CAR T-Cell Therapy Market Size by Application (2023-2035)
        9.3.3 Latin America CAR T-Cell Therapy Market Share by Application (2017-2035)
    9.4 Latin America CAR T-Cell Therapy Market Size by Country
        9.4.1 Latin America CAR T-Cell Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America CAR T-Cell Therapy Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2017-2035)
    10.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa CAR T-Cell Therapy Market Share by Type (2017-2035)
    10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa CAR T-Cell Therapy Market Share by Application (2017-2035)
    10.4 Middle East & Africa CAR T-Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Celgene (Juno Therapeutics)
        11.1.1 Celgene (Juno Therapeutics) Company Details
        11.1.2 Celgene (Juno Therapeutics) Business Overview
        11.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
        11.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.1.5 Celgene (Juno Therapeutics) Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis CAR T-Cell Therapy Introduction
        11.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Gilead (Kite Pharma)
        11.3.1 Gilead (Kite Pharma) Company Details
        11.3.2 Gilead (Kite Pharma) Business Overview
        11.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
        11.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.3.5 Gilead (Kite Pharma) Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer CAR T-Cell Therapy Introduction
        11.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.4.5 Pfizer Recent Developments
    11.5 CARsgen Therapeutics
        11.5.1 CARsgen Therapeutics Company Details
        11.5.2 CARsgen Therapeutics Business Overview
        11.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
        11.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.5.5 CARsgen Therapeutics Recent Developments
    11.6 Autolus Therapeutics
        11.6.1 Autolus Therapeutics Company Details
        11.6.2 Autolus Therapeutics Business Overview
        11.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
        11.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.6.5 Autolus Therapeutics Recent Developments
    11.7 Aurora BioPharma
        11.7.1 Aurora BioPharma Company Details
        11.7.2 Aurora BioPharma Business Overview
        11.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
        11.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.7.5 Aurora BioPharma Recent Developments
    11.8 Sorrento Therapeutics
        11.8.1 Sorrento Therapeutics Company Details
        11.8.2 Sorrento Therapeutics Business Overview
        11.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
        11.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.8.5 Sorrento Therapeutics Recent Developments
    11.9 Mustang Bio
        11.9.1 Mustang Bio Company Details
        11.9.2 Mustang Bio Business Overview
        11.9.3 Mustang Bio CAR T-Cell Therapy Introduction
        11.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.9.5 Mustang Bio Recent Developments
    11.10 Bluebird Bio
        11.10.1 Bluebird Bio Company Details
        11.10.2 Bluebird Bio Business Overview
        11.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
        11.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.10.5 Bluebird Bio Recent Developments
    11.11 Collectis
        11.11.1 Collectis Company Details
        11.11.2 Collectis Business Overview
        11.11.3 Collectis CAR T-Cell Therapy Introduction
        11.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.11.5 Collectis Recent Developments
    11.12 Allogene Therapeutics
        11.12.1 Allogene Therapeutics Company Details
        11.12.2 Allogene Therapeutics Business Overview
        11.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
        11.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.12.5 Allogene Therapeutics Recent Developments
    11.13 Celyad
        11.13.1 Celyad Company Details
        11.13.2 Celyad Business Overview
        11.13.3 Celyad CAR T-Cell Therapy Introduction
        11.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2017-2022)
        11.13.5 Celyad Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global CAR T-Cell Therapy Market